This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • A three part, staggered cohort, open-label and dou...
Clinical trial

A three part, staggered cohort, open-label and double blind, randomized, placebo controlled study to investigate the efficacy, safety, tolerability and pharmacokinetics of eltrombopag, a thrombopoietin receptor agonist, in previously treated pediatric pat

Read time: 1 mins
Last updated:6th Jul 2009
To assess the efficacy of eltrombopag, relative to placebo, in achieving a platelet count ?50Gi/L at any time during a 6 week treatment period when administered to previously treated pediatric subjects with chronic ITP.
Category Value
Study start date 2009-07-06

View full details